NAD Says “Not So Fast” To Antihistamine Claims, Ad Disclosure
This article was originally published in The Tan Sheet
Executive Summary
A National Advertising Division case involving claims for Schering-Plough's Claritin RediTabs underscores that an accurate disclosure cannot redeem a misleading claim